Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study finds early marker for kidney failure:

This article was originally published in Clinica

Executive Summary

A US study has found a protein that might help diagnose kidney failure quickly and early in children who have undergone heart surgery. Testing for high levels of the marker neutrophil gelatinase-associated lipocalin in serum or urine could diagnose kidney failure in two hours, versus one to three days using the current serum creatinine test, according to findings published in The Lancet (April 2). "Effective therapeutic measures for kidney failure are available but are often administered late because early biomarkers for kidney failure are not available," said study leader, Professor Prasad Devarajan, of the Cincinnati Children's Hospital.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel